PharmExec7h
Astellas Pharma and Yaskawa Electric Sign Definitive Agreement to Launch New Cell Therapy Manufacturing Organization
Joint venture is expected to leverage Astellas' expertise in cell therapy R&D and Yaskawa’s robotics technology to enhance ...
PharmExec7h
FDA Approves ARS Pharmaceuticals’ neffy for Type 1 Allergic Reactions in Pediatric Patients
The approval of neffy marks the first major advancement in epinephrine delivery for patients over four years of age in more ...
PharmExec15h
HEOR: From Proving Product Value to Proving Its Own Worth
The recent shift in Health Economics and Outcomes Research functions across major pharmaceutical companies highlights a lack ...
PharmExec12h
Healthcare’s Visual Future: Shaping Trust Through Design
The six key design trends of 2025 redefine how healthcare brands can inspire trust and build lasting connections with their ...
PharmExec15h
Insights on UpScriptHealth’s Recent Pfizer Partnership & Its Impact on Drug Access
In this Pharmaceutical Executive Video Interview, Peter Ax, Founder & CEO of UpScriptHealth, describes how his company's ...